NCI Cancer Bulletin: A Trusted Source for Cancer Research News
NCI Cancer Bulletin: A Trusted Source for Cancer Research News
February 15, 2005 • Volume 2 / Number 7 E-Mail This Document  |  View PDF Version  |  Bulletin Archive/Search  |  Subscribe


Bulletin Home

Featured Article
NCI Announces Senior Leadership Changes

Director's Update
CTWG to Unveil Draft Proposal and Invite Continuing Input at NCAB

Special Report
Smoking Cessation Program Improves Overall and Lung Cancer Survival

Cancer Research Highlights
APC Trial Safety Data Published

Zinc Deficiency and Risk of Esophageal Cancer

Two Studies Find Cause of Pediatric Brain Cancer

Circadian Rhythms May Influence Chemo Toxicity

Neoadjuvant Therapy and Surgery in Breast Cancer Treatment

Featured Clinical Trial
Treating Kidney Tumors in Patients With Von Hippel-Lindau Disease

Funding Opportunities

NCI Gold Star Awards

Notes
NCI Releases Software for Sharing Microarray Data

NCI Workshop Identifies Strategies and Priorities for Biomarker Discovery

Langer to Present at NCI Nanotechnology Seminar Series

Community Update
NCI, FDA Sponsor Biomarker Meeting

Bulletin Archive

Page Options
Print This Page  Print This Page
Print This Document  Print This Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
PDF Version  View/Print PDF
Funding Opportunities

The following are newly-released NCI research funding opportunities:

Research on Sleep and Sleep Disorders
PA-05-046
Application Receipt Dates: May 10 and
Sept. 10, 2005; Jan. 10, May 10, and
Sept. 10, 2006; Jan. 10, May 10, and
Sept. 10, 2007; Jan. 10 and May 10, 2008

This funding opportunity will use the NIH R01 and R21 award mechanisms. For more information see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=2560. Inquiries: Dr. Ann O'Mara, R.N. - ao45s@nih.gov.

Protein Biomarkers of Infection-Associated Cancers
PA-05-048
Application Receipt Dates: May 10 and
Sept. 10, 2005; Jan. 10, May 10, and
Sept. 10, 2006; Jan. 10, May 10, and
Sept. 10, 2007; Jan. 10, 2008

This funding opportunity will use the R01 and R21 award mechanisms. For more information see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=2562. Inquiries: Dr. Karl Krueger - kruegerk@mail.nih.gov.

Units for HIV/AIDS Clinical Trials Networks
RFA-AI-05-002
Letter of Intent Receipt Date: Jun. 10, 2005.
Application Receipt Date: Jul. 11, 2005.

This funding opportunity will use the U01 award mechanisms. For more information see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=2561. Inquiries: Office of the Director - FY06UNITRFA@niaid.nih.gov.

Predoctoral Clinical Research Training Programs
RFA-RM-05-015
Letter of Intent Receipt Date: Feb. 25, 2005.
Application Receipt Date: Mar. 25, 2005.

For more information on predoctoral clinical research programs see http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-05-015.html. Application materials for this process are posted at http://grants.nih.gov/grants/funding/phs398/phs398.html.

Multidisciplinary Clinical Research Career Development Programs
RFA-RM-04-00

Applications for this RFA must be prepared using the PHS 398 forms, available online at http://grants.nih.gov/grants/funding/phs398/phs398.html.


For comprehensive information about NCI funding priorities and opportunities, go to http://www.cancer.gov/researchandfunding.

The NIH Roadmap for Medical Research Funding provides a framework of the priorities NIH must address to optimize its research portfolio. It identifies the most compelling opportunities in three main areas: new pathways to discovery, research teams of the future, and re-engineering the clinical research enterprise. Newly released Roadmap funding opportunities are listed below. For information on additional Roadmap funding opportunities, go to http://nihroadmap.nih.gov.

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov